IronHealth, the specialty healthcare unit of Ironshore, has increased its capacity of up to $20 million for its life sciences business lines, up from the current limits of $15 million.
Enhanced capacity for product liability coverages will be available for all classes of business within the life sciences unit, including pharmaceutical, biotechnological and medical device manufacturing.
“IronHealth’s increase in available capacity for this specialty market sector reflects our continued commitment to provide responsive insurance solutions for clients and broker partners in this rapidly and evolving market,” said Matt Dolan, president of IronHealth.